FindTrial
Sign In

A Study to evaulate the efficacy of Dadrughna Lepa in Fungal Dermatophytosis.

A Randomized open labelled controlled clinical study to evaulate the efficacy of Dadrughna Lepa in the management of Dadu Kushta with special reference to Fungal Dermatophytosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052676
Enrollment
30
Registered
2023-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Dr VISHNU S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: SUBJECTS FALLING UNDER B36 OF ICD10 CLASSIFICATION,CLINICAL SIGNS AND SYMPTOMS OF DADRU KUSHTA AS DESCRIBED IN CLASSICAL TEXTS (PRESENCE OF UDGATA MANDALA WITH OR WITHOUT OTHER SYMPTOMS),SUBJECTS WILLING TO PARTICIPATE IN THE STUDY WITH WRITTEN INFORMED CONSENT WHICH IS CONVEYED IN THE LANGUAGE WHICH THE SUBJECT CAN UNDERSTAND

Exclusion criteria

Exclusion criteria: PREGNANT AND LACTATING WOMEN. SUBJECTS HAVING ANY UNCONTROLLED SYSTEMIC ILLNESS WHICH CAN INTERFERE WITH THE COURSE OF DISESASE AND TREATMENT, OTHER OVERLAPPING DERMATOLOGICAL DISEASES WILL BE EXCLUDED, SUBJECTS UNDER ANTI-FUNGAL DRUGS WILL BE EXCLUDED.

Design outcomes

Primary

MeasureTime frame
Changes in KASI scoreTimepoint: before intervention-0th day during intervention-10th day after intervention-21st day follow up-28th day—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr VISHNU S

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH HOSPITAL, BENGALURU

upsprasad@gmail.com9743893056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026